Skip to main content
Key Specialties
Anesthesiology Cardiology Dermatology Diabetology Endocrinology Gastroenterology General Medicine Geriatrics Hematology Infectious Diseases Internal Medicine Nephrology Neurology Obstetrics and Gynecology Oncology Ophthalmology Pediatrics Psychiatry Radiology Respiratory Medicine Rheumatology Surgery Urology
Congress Coverage
ASH 2024 Annual Meeting 2024 ESMO Congress 2024 ERS Congress 2024 EASD Congress 2024 ESC Congress 2024 EAN Congress 2024 ASCO Annual Meeting 2024 ACC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on adolescent vaping

LIVE: Wednesday 29th January, 18:00-19:30 CET

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in:

09-07-2022 | Breast Cancer | ASO Research Letter

‘At All Costs’: Breast Cancer Patient Responses to Cost Transparency and Communication

Authors: Lily A. Gutnik, MD, MPH, Laura J. Fish, PhD, MPH, Jennifer Gallagher, BA, Rachel A. Greenup, MD, MPH

Published in: Annals of Surgical Oncology | Issue 12/2022

Login to get access

Excerpt

Cancer-related healthcare costs are projected to rise from $183 billion in 2015 to $246 billion in 2030, a growth of over 30%.1 Rising medical expenditures are increasingly shouldered by patients; cost sharing has resulted from reduced insurance coverage leading to high out-of-pocket payment. Cancer-related financial hardship is associated with material and health-related consequences, including employment disruption, increased risk of bankruptcy, treatment non-adherence, poor physical and mental health, and early mortality.2,3 Even among well-insured breast cancer survivors, 33% report significant financial hardship and 80% communicate a desire for upfront cost transparency. …
Literature
1.
Mariotto AB, Enewold L, Zhao J, Zeruto CA, Yabroff KR. Medical Care costs associated with cancer survivorship in the United States. Cancer Epidemiology, Biomarkers and Prevention. 2020;29(7):1304–12.CrossRef
2.
Ramsey SD, Bansal A, Fedorenko CR, et al. Financial insolvency as a risk factor for early mortality among patients with cancer. Journal of Clinical Oncology. 2016;34(9):980.CrossRef
3.
Altice CK, Banegas MP, Tucker-Seeley RD, Yabroff KR. Financial hardships experienced by cancer survivors: a systematic review. Journal of the National Cancer Institute. 2017;109(2):205.CrossRef
4.
Meropol NJ, Schrag D, Smith TJ, et al. American society of clinical oncology guidance statement: the cost of cancer care. Journal of Clinical Oncology. 2009;27(23):3868–74.CrossRef
5.
Yabroff KR, Bradley C, Shih YT. Understanding financial hardship among cancer survivors in the United States: strategies for prevention and mitigation. Journal of Clinical Oncology. 2020;38(4):292–301.CrossRef
6.
Harrington NG, Scott AM, Spencer EA. Working toward evidence-based guidelines for cost-of-care conversations between patients and physicians: a systematic review of the literature. Social Science and Medicine. 2020;258:113084.CrossRef
Metadata
Title
‘At All Costs’: Breast Cancer Patient Responses to Cost Transparency and Communication
Authors
Lily A. Gutnik, MD, MPH
Laura J. Fish, PhD, MPH
Jennifer Gallagher, BA
Rachel A. Greenup, MD, MPH
Publication date
09-07-2022
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 12/2022
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-022-12160-5

Other articles of this Issue 12/2022

ASO Author Reflections: Are Fecal Microbes Associated With Outcomes After Esophageal Cancer Surgery?

A Translational Randomized Trial of Perioperative Arginine Immunonutrition on Natural Killer Cell Function in Colorectal Cancer Surgery Patients

Prevalence of Pathologic N2/N3 Disease in Postmenopausal Women with Clinical N0 ER+/HER2− Breast Cancer

ASO Visual Abstract: Molecular Basis of Extramural Vascular Invasion (EMVI) in Colorectal Carcinoma

  • ASO Visual Abstract

Sentinel Lymph Node Biopsy Alone is Adequate for Chemotherapy Decisions in Postmenopausal Early-Stage Hormone-Receptor-Positive, HER2-Negative Breast Cancer with One to Three Positive Sentinel Lymph Nodes

Assessment of the PARITY Sub-Analysis “Neoadjuvant Chemotherapy and Endoprosthetic Reconstruction for Lower Extremity Sarcomas: Does Timing Impact Complication Rates?”

SPONSORED

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

  • Webinar | 06-02-2024 | 20:00 (CET)

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by:
  • Viatris
Developed by: Springer Healthcare
Watch now
Image Credits